Product Information
NEURONTIN 400 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $8.8672 per EA under NDC 58151028301. Its NADAC has been published 38 times since Dec 3, 2025.
FDA first approved this application on Dec 30, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151028301
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
GABAPENTINApproval Type
New Drug (NDA)
FDA Application
NDA020235FDA Approved
12/30/1993
TE Code
AB
On Market Since
10/1/2025
Pharmacological Classes
Price Statistics
The NADAC for NEURONTIN 400 MG CAPSULE has been published 38 times since Dec 3, 2025, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8672 per EA |
|---|---|
| All-time high | $8.8672 (Aug 19, 2026) |
| All-time low | $8.4449 (Dec 3, 2025) |
| 52-week high | $8.8672 |
| 52-week low | $8.4449 |
| Median price | $8.8672 |
| Average price | $8.8116 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 38 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NEURONTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NEURONTIN 400 MG CAPSULE, manufactured by Viatris Specialty LLC, is $8.8672 per EA (NDC 58151028301), effective Aug 19, 2026.
How has the price of NEURONTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NEURONTIN 400 MG CAPSULE has risen 5.0%. It has been tracked across 38 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for NEURONTIN 400 MG CAPSULE?
Since Dec 3, 2025, the NADAC for NEURONTIN 400 MG CAPSULE has ranged from a low of $8.4449 (Dec 3, 2025) to a high of $8.8672 (Aug 19, 2026), with a median of $8.8672 per EA.
Are there cheaper alternatives to NEURONTIN 400 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 400 MG CAPSULE, is $0.0400 per EA — about 99% below NEURONTIN 400 MG CAPSULE.
Who manufactures NEURONTIN 400 MG CAPSULE?
NEURONTIN 400 MG CAPSULE (NDC 58151028301) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.